
Evogene Ltd. EVGN
$ 1.03
-1.39%
Annual report 2024
added 12-13-2025
Evogene Ltd. Cash Conversion Cycle 2011-2025 | EVGN
Annual Cash Conversion Cycle Evogene Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | -32.5 | 32.6 | -26.2 | -30.8 | -21.1 | -56.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32.6 | -56.2 | -22.4 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.78 | 2.03 % | $ 793 M | ||
|
Aclaris Therapeutics
ACRS
|
-881 | $ 3.06 | 5.34 % | $ 237 M | ||
|
Aptevo Therapeutics
APVO
|
-47.4 | $ 0.96 | -6.37 % | $ 265 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
166 | $ 27.0 | 2.08 % | $ 1.31 B | ||
|
Anika Therapeutics
ANIK
|
270 | $ 9.51 | 1.22 % | $ 139 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Catalyst Biosciences
CBIO
|
391 | $ 12.13 | 0.12 % | $ 799 M | ||
|
Axon Enterprise
AXON
|
86.2 | $ 590.57 | -0.08 % | $ 44.7 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.5 | -1.57 % | $ 15.7 M | ||
|
AstraZeneca PLC
AZN
|
-58 | $ 92.54 | 0.43 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
149 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
209 | $ 10.62 | 0.85 % | $ 687 M | ||
|
Biogen
BIIB
|
387 | $ 176.58 | 1.01 % | $ 25.7 B | ||
|
Abeona Therapeutics
ABEO
|
387 | $ 5.46 | 2.94 % | $ 117 M | ||
|
Celldex Therapeutics
CLDX
|
-6.08 K | $ 26.83 | 0.92 % | $ 1.73 M | ||
|
ADiTx Therapeutics
ADTX
|
-4.31 K | $ 1.14 | -9.52 % | $ 15 K | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
214 | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
-32.7 | - | - | - | ||
|
Фармсинтез
LIFE
|
-15.9 | - | - | - |